Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Poster Session

$Thumbnail for DAYBreak CLL-306: A Phase 3 Randomized Open-Label Trial of the Novel Bruton Tyrosine Kinase Degrader Bexobrutideg (NX-5948) vs Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma$

CLL - 432

DAYBreak CLL-306: A Phase 3 Randomized Open-Label Trial of the Novel Bruton Tyrosine Kinase Degrader Bexobrutideg (NX-5948) vs Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Megan Wang

Poster Presenter: Megan Wang

Thumbnail for Efficacy and Safety of Pirtobrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis

CLL - 437

Efficacy and Safety of Pirtobrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for The Impact of Baseline Immune-Inflammatory Indices and Microenvironment in Richter Transformation: A Case Series

CLL - 444

The Impact of Baseline Immune-Inflammatory Indices and Microenvironment in Richter Transformation: A Case Series

Maria D'Amato

Poster Presenter: Maria D'Amato

Thumbnail for Comparative Assessment of MRD Detection and Immunological Effects in Relapsed CLL Patients Treated With Rituximab-Venetoclax in Real World: Insights From the “Dedalus" Protocol

CLL - 446

Comparative Assessment of MRD Detection and Immunological Effects in Relapsed CLL Patients Treated With Rituximab-Venetoclax in Real World: Insights From the “Dedalus" Protocol

Maria D'Amato

Poster Presenter: Maria D'Amato

Thumbnail for Progressive Multifocal Leukoencephalopathy in Chronic Lymphocytic Leukemia During Venetoclax-Obinutuzumab Therapy: A Rare but Fatal Complication

CLL - 447

Progressive Multifocal Leukoencephalopathy in Chronic Lymphocytic Leukemia During Venetoclax-Obinutuzumab Therapy: A Rare but Fatal Complication

Nour Haidar

Poster Presenter: Nour Haidar

Thumbnail for Comparative Efficacy and Safety of Pirtobrutinib Versus Covalent BTK Inhibitors in Treatment-Naοve Chronic Lymphocytic Leukemia: A Systematic Review and Bayesian Network Meta-Analysis

CLL - 450

Comparative Efficacy and Safety of Pirtobrutinib Versus Covalent BTK Inhibitors in Treatment-Naοve Chronic Lymphocytic Leukemia: A Systematic Review and Bayesian Network Meta-Analysis

Pakeeza Saif

Poster Presenter: Pakeeza Saif

Thumbnail for Real-World Clinical Outcomes of Targeted Therapy in a Pakistani Cohort of Chronic Lymphocytic Leukemia

CLL - 465

Real-World Clinical Outcomes of Targeted Therapy in a Pakistani Cohort of Chronic Lymphocytic Leukemia

Munira Borhany

Poster Presenter: Munira Borhany

Thumbnail for Real-World Comparative Analysis of Treatment Discontinuation (TD) with Covalent Bruton Tyrosine Kinase Inhibitors (cBTKis) in First-Line (1L) Chronic Lymphocytic Leukemia (CLL)

CLL - 476

Real-World Comparative Analysis of Treatment Discontinuation (TD) with Covalent Bruton Tyrosine Kinase Inhibitors (cBTKis) in First-Line (1L) Chronic Lymphocytic Leukemia (CLL)

Derrick van Beuge

Poster Presenter: Derrick van Beuge

Thumbnail for How Many Lines of Therapy Do Patients With CLL/SLL Receive in Routine Clinical Practice in the United States? Real-World Evidence From the Targeted Therapy Era

CLL - 560

How Many Lines of Therapy Do Patients With CLL/SLL Receive in Routine Clinical Practice in the United States? Real-World Evidence From the Targeted Therapy Era

Deborah M. Stephens

Poster Presenter: Deborah M. Stephens

Previous 1...52 53 54 55 56 57 58...139 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors